
News from Express Pharma
Top Express Pharma News

United States · United StatesZydus Lifesciences Ltd has been tentatively approved by the USFDA for its generic Ibrutinib tablets. These tablets, used to treat blood cancers, will be manufactured in Ahmedabad. According to IQVIA data, the Ibrutinib market generated USD 2.15 billion in the US in 2025.See the Story
Zydus Lifesciences Secures Tentative FDA Nod for Generic Cancer Drug
100% Center coverage: 2 sources

United States · United StatesZydus Lifesciences Ltd has been tentatively approved by the USFDA for its generic Ibrutinib tablets. These tablets, used to treat blood cancers, will be manufactured in Ahmedabad. According to IQVIA data, the Ibrutinib market generated USD 2.15 billion in the US in 2025.See the Story
Zydus Lifesciences Secures Tentative FDA Nod for Generic Cancer Drug
100% Center coverage: 2 sources